Screening and novel therapies for retinopathy of prematurity - A review.

With current screening for sight threatening retinopathy of prematurity (ROP) <10% of screened infants need treatment. Prediction models based on birth characteristics, postnatal weight gain and other factors have been developed to reduce examinations in low-risk infants. A model based on advanced statistics using data from >7000 infants registered in the Swedish ROP registry is being developed. Based on birth characteristics only, it appears to predict total risk of ROP-treatment as well as models including weight measurements. Treatment risk peaked at 12 weeks of age. Laser therapy is the method of choice for severe ROP. Anti-VEGF therapies are implemented worldwide despite insufficient knowledge of choice of drug, dosage and long term systemic effects. Prevention of ROP may be achieved through oxygen control and provision of the mother's breastmilk. Other interventions such as supplementation with long chain polyunsaturated fatty acids and preservation of fetal haemoglobin are investigated.

• Publication year

  2019

• Venue

  Early Human Development

• Publication date

  2019-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.earlhumdev.2019.104846PMID 31474316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Review shows that donor milk does not promote the growth and development of preterm infants as well as maternal milk

  2019cited by this paper
• Retrospective Validation of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Criteria in a Japanese Cohort.

  2019cited by this paper
• Association Between Year of Birth and 1-Year Survival Among Extremely Preterm Infants in Sweden During 2004-2007 and 2014-2016

  2019cited by this paper
• Increased incidence of retinopathy of prematurity and evolving treatment modalities at a Canadian tertiary centre.

  2019cited by this paper
• Enteral Docosahexaenoic Acid and Retinopathy of Prematurity: A Randomized Clinical Trial.

  2019cited by this paper
• Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study

  2019cited by this paper
• Validation of the Colorado Retinopathy of Prematurity Screening Model

  2018cited by this paper
• Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists

  2018cited by this paper
• Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration

  2018cited by this paper
• rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial

  2018cited by this paper
• Increased frequency of retinopathy of prematurity over the last decade and significant regional differences

  2018cited by this paper
• Foetal haemoglobin concentration at postmenstrual age is unaffected by gestational age at birth

  2018cited by this paper
• Umbilical cord blood as a source for red‐blood‐cell transfusion in neonatology: a systematic review

  2018cited by this paper
• Oral propranolol for prevention of threshold retinopathy of prematurity (ROPROP): protocol of a randomised controlled trial

  2018cited by this paper
• Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study

  2018cited by this paper
• A Dosing Study of Bevacizumab for Retinopathy of Prematurity: Late Recurrences and Additional Treatments.

  2018cited by this paper
• Implementation of a Clinical Prediction Model Using Daily Postnatal Weight Gain, Birth Weight, and Gestational Age to Risk Stratify ROP.

  2018cited by this paper
• Dose-response Relationship Between Donor Human Milk, Mother's Own Milk, Preterm Formula, and Neonatal Growth Outcomes

  2018cited by this paper
• Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity

  2018cited by this paper
• Association of Retinopathy of Prematurity With Low Levels of Arachidonic Acid

  2018cited by this paper
• Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: A randomized controlled trial

  2017cited by this paper
• Foetal haemoglobin, blood transfusion, and retinopathy of prematurity in very preterm infants: a pilot prospective cohort study

  2017cited by this paper
• Red Blood Cell Transfusion and Clinical Outcomes in Extremely Low Birth Weight Preterm Infants.

  2017cited by this paper
• Implementing higher oxygen saturation targets reduced the impact of poor weight gain as a predictor for retinopathy of prematurity

  2017cited by this paper
• A worldwide survey of retinopathy of prematurity screening

  2017cited by this paper
• Effects of Donor Breastmilk Feeding on Growth and Early Neurodevelopmental Outcomes in Preterm Infants: An Observational Study.

  2017cited by this paper
• Validation of the Children’s Hospital of Philadelphia Retinopathy of Prematurity (CHOP ROP) Model

  2017cited by this paper
• Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology.

  2017cited by this paper
• Insulin‐like growth factor 1 has multisystem effects on foetal and preterm infant development

  2016cited by this paper
• Neonatal Outcomes of Very Low Birth Weight and Very Preterm Neonates: An International Comparison.

  2016cited by this paper
• The Colorado-retinopathy of prematurity model (CO-ROP): postnatal weight gain screening algorithm.

  2016cited by this paper
• Graded oxygen saturation targets and retinopathy of prematurity in extremely preterm infants

  2016cited by this paper
• Developmental changes in polyunsaturated fetal plasma phospholipids and feto-maternal plasma phospholipid ratios and their association with bronchopulmonary dysplasia

  2016cited by this paper
• Temporal changes in blood product usage in preterm neonates born at less than 30 weeks' gestation in Canada

  2015cited by this paper
• Vascular endothelial growth factor plasma levels before and after treatment of retinopathy of prematurity with ranibizumab

  2015cited by this paper
• Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity.

  2015cited by this paper
• Closed-Loop Automatic Oxygen Control (CLAC) in Preterm Infants: A Randomized Controlled Trial

  2014cited by this paper
• Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study.

  2014cited by this paper
• 未熟児網膜症に対する経口プロプラノロール:リスク,安全性,懸念,視点

  2013cited by this paper
• A mathematical modeling approach to quantify the role of phlebotomy losses and need for transfusions in neonatal anemia

  2013cited by this paper
• Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010

  2013cited by this paper
• Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A Randomized, Controlled Trial. I: Primary Outcomes

  2013cited by this paper
• VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration

  2013cited by this paper
• Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives.

  2013cited by this paper
• A predictive score for retinopathy of prematurity in very low birth weight preterm infants

  2012cited by this paper
• Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity.

  2012cited by this paper
• The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model.

  2012cited by this paper
• 5-Lipoxygenase Metabolite 4-HDHA Is a Mediator of the Antiangiogenic Effect of ω-3 Polyunsaturated Fatty Acids

  2011cited by this paper
• Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.

  2011cited by this paper
• Improved growth of preterm infants receiving mother’s own raw milk compared with pasteurized donor milk

  2011cited by this paper
• A Clinical Prediction Model to Stratify Retinopathy of Prematurity Risk Using Postnatal Weight Gain

  2011cited by this paper
• High or Low Oxygen Saturation and Severe Retinopathy of Prematurity: A Meta-analysis

  2010cited by this paper
• Early Weight Gain Predicts Retinopathy in Preterm Infants: New, Simple, Efficient Approach to Screening

  2009cited by this paper
• Anti-vascular endothelial growth factor and retinopathy of prematurity

  2008cited by this paper
• Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis

  2007cited by this paper
• Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity.

  2006cited by this paper
• Can Screening for Retinopathy of Prematurity Be Reduced?

  2005cited by this paper
• Randomized Trial of Donor Human Milk Versus Preterm Formula as Substitutes for Mothers' Own Milk in the Feeding of Extremely Premature Infants

  2005cited by this paper
• Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants?

  2003cited by this paper
• On "supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: Primary outcomes".

  2000cited by this paper
• Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes.

  2000cited by this paper
• Towards a universal approach for screening of retinopathy of prematurity (ROP)

  1996cited by this paper
• Transcutaneous oxygen levels in retinopathy of prematurity.

  1995cited by this paper
• Exposure to Alternating Hypoxia and Hyperoxia Causes Severe Proliferative Retinopathy in the Newborn Rat

  1994cited by this paper
• The Pattern of Fetal Haemoglobin Disappearance after Birth

  1976cited by this paper

• Discontinuation of automated oxygen control in preterm infants in the NICU: A 5-year single centre real-world experience.

  2025cites this paper
• Extracellular vesicles and preterm infant diseases

  2025cites this paper
• Systematic review and meta-analysis of risk prediction models for retinopathy of prematurity in preterm infants

  2025cites this paper
• Incidence and Risk Factors of Retinopathy of Prematurity in Southeastern Iran: A Retrospective Cohort Study

  2024cites this paper
• Comparison of two different oxygen saturation target ranges for automated oxygen control in preterm infants: a randomised cross-over trial

  2024cites this paper
• Cytokine and growth factor correlation networks associated with morbidities in extremely preterm infants

  2024cites this paper
• Retinopathy of Prematurity in Eight Portuguese Neonatal Intensive Care Units: Incidence, Risk Factors, and Progression—A Prospective Multicenter Study

  2024cites this paper
• Risk factors for the time to development of retinopathy of prematurity in premature infants in Iran: a machine learning approach

  2024cites this paper
• Mechanical Ventilation, Retinal Avascularity and Rate of Vascularisation: A Triad of Predictors for Retinopathy of Prematurity Treatment

  2024cites this paper
• A Network Meta-Analysis of Success Rates following Low Dosage Anti-VEGF for Retinopathy of Prematurity

  2023cites this paper
• Harnessing the therapeutic potential of the stem cell secretome in neonatal diseases.

  2023cites this paper
• Neurosensory Alterations in Retinopathy of Prematurity: A Window to Neurological Impairments Associated to Preterm Birth

  2022cites this paper
• Morphology and biological data in cord blood eryhtrocyte units resembles adult units after processing and storage - Meets current quality recommendations.

  2022cites this paper
• Decoupling Oxygen Tension From Retinal Vascularization as a New Perspective for Management of Retinopathy of Prematurity. New Opportunities From β-adrenoceptors

  2022cites this paper
• Prediction model to predict type 1 retinopathy of prematurity using gestational age and birth weight (PW-ROP)

  2022cites this paper
• Evaluation of the Retinopathy of Prematurity Activity Scale (ROP-ActS) in a randomised controlled trial aiming for prevention of severe ROP: a substudy of the Mega Donna Mega trial

  2022cites this paper
• Clinical outcomes of preterm infants while using automated controllers during standard care: comparison of cohorts with different automated titration strategies

  2022cites this paper
• Effect of Optimizing Oxygen Saturation Targets on the Incidence of Retinopathy of Prematurity in a Quaternary NICU

  2022cites this paper
• Extended Abstracts: IXth Recent Advances in Neonatal Medicine. An International Symposium Honoring Prof. B. Johnston Jr., October 1–3, 2021

  2021cites this paper
• Concurrent Physiological and Pathological Angiogenesis in Retinopathy of Prematurity and Emerging Therapies

  2021cites this paper
• The Nrf2 inhibitor brusatol has a protective role in a rat model of oxygen-induced retinopathy of prematurity

  2021cites this paper
• Incidence and risk factors of retinopathy of prematurity in an Italian cohort of preterm infants

  2021cites this paper
• The effect of automated oxygen control on clinical outcomes in preterm infants: a pre- and post-implementation cohort study

  2021cites this paper
• Inflammatory biomarkers in very preterm infants during early intravenous paracetamol administration.

  2021cites this paper
• Eph Receptors and Ephrins in Retinal Diseases

  2021cites this paper
• Comparison of two devices for automated oxygen control in preterm infants: a randomised crossover trial

  2021cites this paper
• G-protein coupled estrogen receptor activation protects the viability of hyperoxia-treated primary murine retinal microglia by reducing ER stress

  2020cites this paper
• Extended Abstracts: IXth Recent Advances in Neonatal Medicine. An International Symposium Honoring Prof. Richard B. Johnston Jr., MD, Denver, CO. Würzburg, October 1–3, 2021

  2020cites this paper
• ORIGINAL ARTICLES

  year unknowncites this paper
• To study the significance of various risk factors in development of retinopathy of prematurity at a tertiary care center in Eastern Uttar Pradesh

  year unknowncites this paper